Literature DB >> 10815120

Patient characteristics and ICU organizational factors that influence frequency of pulmonary artery catheterization.

J Rapoport1, D Teres, J Steingrub, T Higgins, W McGee, S Lemeshow.   

Abstract

CONTEXT: Hemodynamic monitoring of patients with a pulmonary artery catheter is controversial because there are few data confirming its effectiveness, and patient and intensive care unit (ICU) organizational factors associated with its use are unknown.
OBJECTIVE: To determine pulmonary artery catheter use in relationship to type of ICU organization and staffing, and patient characteristics, including severity of illness and insurance coverage. DESIGN, SETTING, AND PATIENTS: Retrospective database study of 10,217 nonoperative patients who received treatment at 34 medical, mixed medical and surgical, and surgical ICUs at 27 hospitals during 1998 (patients were enrolled in Project IMPACT). MAIN OUTCOME MEASURES: Pulmonary artery catheter use based on severity of illness measured by the Simplified Acute Physiology Score, resuscitation status at ICU admission, and ICU organizational variables, including type, size, and model.
RESULTS: A pulmonary artery catheter was used for 831 patients (8.1%) in the ICU. In multivariate analysis adjusted for severity of illness, age, diagnosis, and do-not-resuscitate status, full-time ICU physician staffing was associated with a two-thirds reduction in the probability of catheter use (odds ratio [OR], 0.36; 95% confidence interval [CI], 0.28-0.45). Higher catheter use was associated with white race (OR, 1.38; 95% CI, 1.10-1.72) and private insurance coverage (OR, 1.33; 95% CI, 1.10-1.60). Admission to a surgical ICU was associated with a 2-fold increase in probability of catheter use (OR, 2.17; 95% CI, 1.70-2.76) compared with either medical or mixed medical and surgical ICUs.
CONCLUSION: Organizational characteristics of ICUs, insurance reimbursement, and race, as well as clinical variables, are associated with variation in practice patterns regarding pulmonary artery catheter use. Understanding such influences, combined with studies measuring clinical and economic outcomes, can contribute to the development of policies for the rational use of pulmonary artery catheters. JAMA. 2000;283:2559-2567

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health; Professional Patient Relationship

Mesh:

Year:  2000        PMID: 10815120     DOI: 10.1001/jama.283.19.2559

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  27 in total

1.  Results from the National Sepsis Practice Survey: use of drotrecogin α (activated) and other therapeutic decisions.

Authors:  James M O'Brien; Scott K Aberegg; Naeem A Ali; Gregory B Diette; Stanley Lemeshow
Journal:  J Crit Care       Date:  2010-06-19       Impact factor: 3.425

Review 2.  Healthcare disparities in critical illness.

Authors:  Graciela J Soto; Greg S Martin; Michelle Ng Gong
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

3.  Defining Sepsis Mortality Clusters in the United States.

Authors:  Justin Xavier Moore; John P Donnelly; Russell Griffin; George Howard; Monika M Safford; Henry E Wang
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

4.  Cross-comparisons of trending accuracies of continuous cardiac-output measurements: pulse contour analysis, bioreactance, and pulmonary-artery catheter.

Authors:  Bouchra Lamia; Hyung Kook Kim; Donald A Severyn; Michael R Pinsky
Journal:  J Clin Monit Comput       Date:  2017-02-10       Impact factor: 2.502

Review 5.  An official American Thoracic Society systematic review: the association between health insurance status and access, care delivery, and outcomes for patients who are critically ill.

Authors:  Robert A Fowler; Lori-Anne Noyahr; J Daryl Thornton; Ruxandra Pinto; Jeremy M Kahn; Neill K J Adhikari; Peter M Dodek; Nadia A Khan; Tom Kalb; Andrea Hill; James M O'Brien; David Evans; J Randall Curtis
Journal:  Am J Respir Crit Care Med       Date:  2010-05-01       Impact factor: 21.405

6.  The effect of insurance status on mortality and procedural use in critically ill patients.

Authors:  Sarah M Lyon; Nicole M Benson; Colin R Cooke; Theodore J Iwashyna; Sarah J Ratcliffe; Jeremy M Kahn
Journal:  Am J Respir Crit Care Med       Date:  2011-10-01       Impact factor: 21.405

7.  Medicaid expansion under the Affordable Care Act. Implications for insurance-related disparities in pulmonary, critical care, and sleep.

Authors:  Sarah M Lyon; Ivor S Douglas; Colin R Cooke
Journal:  Ann Am Thorac Soc       Date:  2014-05

Review 8.  Using existing data to address important clinical questions in critical care.

Authors:  Colin R Cooke; Theodore J Iwashyna
Journal:  Crit Care Med       Date:  2013-03       Impact factor: 7.598

9.  Variability in interventions with pulmonary artery catheter data.

Authors:  Manu Jain; Michelle Canham; Daya Upadhyay; Thomas Corbridge
Journal:  Intensive Care Med       Date:  2003-11       Impact factor: 17.440

10.  Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients.

Authors:  Bradley D Freeman; David J Dixon; Craig M Coopersmith; Barbara A Zehnbauer; Timothy G Buchman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-10       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.